GeoVax to Present at the Emerging Growth Conference on August 21, 2024
15. August 2024 09:00 ET
|
GeoVax, Inc.
Company to Discuss Recent Mpox Developments as Well as Milestones Related to theBARDA Project NextGen Award for Its Next-generation COVID-19 Vaccine ATLANTA, GA, Aug. 15, 2024 (GLOBE NEWSWIRE) --...
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
04. April 2024 12:30 ET
|
GeoVax, Inc.
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
06. März 2024 09:00 ET
|
GeoVax, Inc.
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
DHSS launches interactive statewide flu dashboard
13. Oktober 2023 17:00 ET
|
Missouri Department of Health and Senior Services
JEFFERSON CITY, Mo., Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Missouri Department of Health and Senior Services (DHSS) has published the first Weekly Influenza Surveillance Report of the 2023-2024 flu...
COVID-19 Vaccine Market Predicted to Reach USD 9.9 billion by 2031, Garnering -13.6% CAGR: TMR Report
14. September 2023 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The COVID-19 vaccine market was estimated to have acquired US$ 92.6 billion in 2021. It is...
FFF Enterprises Inc. Adds COVID-19 Vaccines and Respiratory Syncytial Virus (RSV) Products to Its Comprehensive, Expanding Portfolio
13. September 2023 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with...
GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates
31. Mai 2023 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
24. Mai 2023 08:00 ET
|
GeoVax, Inc.
New and Unpublished Data from Phase 2 Open-Label Safety Study ofGEO-CM04S1 Presented at Two Recent Scientific Meetings ATLANTA, GA, May 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs,...
‘Negative Evidence’ on COVID-19 Vaccines and Cancer Reviewed in the Journal of American Physicians and Surgeons (AAPS)
21. März 2023 11:32 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2023 (GLOBE NEWSWIRE) -- Given the dread that the thought of cancer inspires, and anecdotal reports of cancer manifesting soon after a COVID-19 vaccination, the lack of...
King Faisal Prize Awards $1 Million, in Recognition of COVID-19 Vaccine Development, Nanotechnology Ingenuity Contributing to 100 Scientific Breakthroughs that Changed the World, and other Key Scientific & Humanitarian Achievements
20. März 2023 15:22 ET
|
King Faisal Prize
Riyadh, Saudi Arabia, March 20, 2023 (GLOBE NEWSWIRE) -- On 20 March, Harvard University and Oxford University professors Dan Barouch from the US and Sarah Gilbert from the UK received the King...